Opinion

Video

More Is Needed to Connect Clinicians, Patients to Clinical Trials

Author(s):

More facilitation is needed to ensure that clinicians can connect patients with breast cancer to clinical trials they may be eligible for.

More needs to be done to facilitate a connection between oncology nurse navigators and clinical resources to improve enrollment and diversify the patient population involved in research, explained Sue Friedman.

In an interview with CURE®, Friedman, who is the executive director of FORCE (Facing Hereditary Cancer Empowered) discussed a needs assessment conducted by FORCE and supported by the Centers of Disease Control and Prevention (CDC), which highlighted barriers for referrals to supportive care services and clinical trials for young patients with breast cancer.

READ MORE: Knowledge is Power’: Advocating for More Representation in Cancer-Related Clinical Trials

Now, Friedman explained, FORCE will work to facilitate that collaboration to improve clinical trial enrollment and break down barriers to supportive care, such as fertility preservation.

Transcript

Well, there were several big takeaways from our needs assessment, and this poster was really just one component of it, but one was that there was more that we could do as an organization to facilitate connecting oncology nurse navigators with resources around clinical research studies to help encourage them to let patients know more about clinical research studies in order to improve enrollment and diverse involvement in clinical research.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,